5-(4-(2-(3-metoksyfenylo)-2-oksoetoksy)benzylo)tiazolidyno-2,4-dion do stosowania w leczeniu cukrzycy

• 收藏
• 分享

专利权人:

Metabolic Solutions Development Company LLC

发明人:

COLCA, GERARD R.,GADWOOD, ROBERT C.,PARKER, TIM

申请号：

PL08832210

公开号：

PL2203433T3

申请日:

2008.09.15

申请国别(地区):

PL

年份:

2013

代理人:

摘要：

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. Formula (I), wherein: each of R1 and R4 is independently selected from H, halo, aliphatic, and alkoxy, wherein the aliphatic and alkoxy are optionally substituted with 1-3 of halo； R2 is halo, hydroxy, or optionally substituted aliphatic, and R&prime；2 is H, or R2 and R&prime；2 together form oxo； R3 is H； and Ring A is a phenyl.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/